These final results, together with a past report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,two support the concept of targeting ACKR3 as a unique strategy to modulate the opioid program, which could open up new therapeutic avenues for opioid-related Diseases. In reaction to this https://judyq470yup0.wikifrontier.com/user